Bird Flu Treatment Market

Bird Flu Treatment Market by Types (Immunoglobulin, Ribavirin, Antivirals, Steroids, Prophylactic Antibiotics, Combination Treatment, and Others), End-users (Institutional Health Centers, Hospitals, and Clinics) and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

  • Report ID: HC-2342
  • Author: Growth Market Reports
  • Rating: 4.7
  • Total Reviews: 2
  • No. Of Pages: 166
  • Format:
  • Pub. Date: Upcoming
  • Share:

The global bird flu treatment market size is estimated to register a substantial CAGR during the forecast period, 2021–2028. The growth of the market is attributed to the increasing outbreaks of avian influenza in the poultry industry and rising awareness about diagnosis among infected patients globally.

Bird Flu Treatment Market Key Takeaways

Avian influenza is a virus that causes bird flu. It causes sickness in birds, which have the potential to evolve and transmit to people. Depending on the protein found on the virus's surface, bird flu is referred to as H or N. The influenza A, B, and C viruses are the three varieties of influenza viruses. Influenza virus A is classified on the basis of surface proteins hemagglutinin (HA) and neuraminidase. The influenza A virus is further segmented into three categories based on its origin such as avian influenza, swine influenza, and other animal influenza viruses. People are infected with avian influenza through direct contact with contaminated birds. However, avian influenza is a rare disease in humans, it can occur when humans come into close contact with infected birds. A (H5N1) and A (H7N9) are two prevalent viruses that can cause serious illness in humans. Furthermore, the A (H7N9) virus subtype is extremely rare with a low pathogenicity and only found in East Asia. Europe and Africa have had a tremendous impact on many countries, which has resulted in tons of poultry infection and hundreds of human cases of serious disease across geographies.

The COVID-19 pandemic outbreak was an unprecedented global public health crisis that had impacted various industries and its long-term repercussions have had adverse impact on the bird flu treatment market. Furthermore, hospitals and healthcare services were drastically curtailed owing to social distancing measures enacted by governments around the world. Furthermore, the pandemic had a significant impact on the functioning of general hospital treatment for non-COVID-19 patients in hospitals globally.

Market Trends, Drivers, Restraints, and Opportunities

  • Increasing precautionary measures especially in the poultry industry to prevent the spread of bird flu is one of the key factors fueling the market growth.
  • Ongoing R&D activities and rising investment by key players to develop improved products with better safety and efficacy are propelling the market growth.
  • Several initiatives undertaken by government bodies in order to increase awareness about disorders among people are offering good opportunities to fuel the growth of the market in the near future.
  • Unhealthy competition among the key players to secure larger market share is expected to hamper the market growth caused by price erosion.
  • Focusing on regenerative drugs and the preference for combination therapy are expected to provide great opportunity for the market growth in the coming years.

Scope of the Report

The report on the global bird flu treatment market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Bird Flu Treatment Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Types (Immunoglobulin, Ribavirin, Antivirals, Steroids, Prophylactic Antibiotics, Combination Treatment, and Others) and End-users (Institutional Health Centers, Hospitals, and Clinics)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

AbbVie Inc.; Abbott Laboratories; Alltech, Inc.; BioCryst Pharmaceuticals, Inc.; Aurobindo Pharma Ltd.; Cipla Ltd.; Bristol-Myers Squibb Co.; Chewy, Inc.; Dr. Reddy’s Laboratories Ltd.; F. Hoffmann-La Roche AG; Forest Pharmaceuticals, Inc.; GlaxoSmithKline PLC.; Gilead Sciences Inc.; Johnson & Johnson Services, Inc.; Merck & Co.; Macleods Pharmaceuticals Ltd.; Novartis International AG; Sinovac Biotech Ltd.; Pfizer Inc.; and Sanofi S.A.

Market Segment Insights

Antivirals segment is expected to grow at a rapid pace

Based on types, the global bird flu treatment market is segregated into immunoglobulin, ribavirin, antivirals, steroids, prophylactic antibiotics, combination treatment, and others. Antivirals segment is expected to grow at a rapid pace during the forecast period due to high prevalence of viral infections related to bird flu and rising demand for antiviral treatment drugs.

Bird Flu Treatment Market By Types

Hospital segment is projected to expand at a considerable CAGR

On the basis of end-users, the market is segmented into institutional health centers, hospitals, and clinics. The hospital segment is projected to expand at a considerable CAGR during the forecast period owing to the rise in adopting of POC tests in the hospital diagnosis of infection and examine disease progression based on symptoms or other parameters.

On the other hand, the clinic segment is expected to grow at a considerable rate in the market during the forecast period as it is cost-effective and easy products available in the market. This clinical diagnosis and treatment is a key method that can help medical workers to take decision quickly and address the problems more accurately.

North America is anticipated to constitute a key market share

In terms of regions, the global bird flu treatment market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share during the projected period attributed to the encouraging reimbursement policies and increasing awareness about diseases transmitted from birds. In addition, the presence of major players such as Pfizer and Alcon in the region is expected to further promote the regional market growth.

On the other hand, the market of Asia Pacific is expected to represent a substantial market share in the coming years. The growth of the region attributed to the increasing investment in drugs development and growing number of clinical studies to evaluate the various alternative treatment procedures in the region.

Bird Flu Treatment Market By Regions

Segments

Segments Covered in the Report
The global bird flu treatment market has been segmented on the basis of

Types
  • Immunoglobulin
  • Ribavirin
  • Antivirals
  • Steroids
  • Prophylactic Antibiotics
  • Combination Treatment
  • Others
End-users
  • Institutional Health Centers
  • Hospitals
  • Clinics
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • AbbVie Inc.
  • Abbott Laboratories
  • Alltech, Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Aurobindo Pharma Ltd.
  • Cipla Ltd.
  • Bristol-Myers Squibb Co.
  • Chewy, Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • F. Hoffmann-La Roche AG
  • Forest Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC.
  • Gilead Sciences Inc.
  • Johnson & Johnson Services, Inc.
  • Merck & Co.
  • Macleods Pharmaceuticals Ltd.
  • Novartis International AG
  • Sinovac Biotech Ltd.
  • Pfizer Inc.
  • Sanofi S.A.

Competitive Landscape

Some of the major players competing in the market are AbbVie Inc.; Abbott Laboratories; Alltech, Inc.; BioCryst Pharmaceuticals, Inc.; Aurobindo Pharma Ltd.; Cipla Ltd.; Bristol-Myers Squibb Co.; Chewy, Inc.; Dr. Reddy’s Laboratories Ltd.; F. Hoffmann-La Roche AG; Forest Pharmaceuticals, Inc.; GlaxoSmithKline PLC.; Gilead Sciences Inc.; Johnson & Johnson Services, Inc.; Merck & Co.; Macleods Pharmaceuticals Ltd.; Novartis International AG; Sinovac Biotech Ltd.; Pfizer Inc.; and Sanofi S.A. These major players are implementing various marketing strategies such as capital investments, merger & acquisitions, and new product development to enhance their market position in the regional as well as global competition.

Bird Flu Treatment Market By Key Players

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Bird Flu Treatment Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Bird Flu Treatment Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Bird Flu Treatment Market - Supply Chain
  4.5. Global Bird Flu Treatment Market Forecast
     4.5.1. Bird Flu Treatment Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Bird Flu Treatment Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Bird Flu Treatment Market Absolute $ Opportunity
5. Global Bird Flu Treatment Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Bird Flu Treatment Market Size and Volume Forecast by Applications
     5.3.1. Immunoglobulin Ribavirin Antivirals Steroids Prophylactic Antibiotics Combination Treatment  
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Bird Flu Treatment Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Bird Flu Treatment Market Size and Volume Forecast by End Users
     6.3.1. Institutional Health Centers Hospitals Clinics
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Bird Flu Treatment Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Bird Flu Treatment Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Bird Flu Treatment Demand Share Forecast, 2019-2026
8. North America Bird Flu Treatment Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Bird Flu Treatment Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Bird Flu Treatment Market Size and Volume Forecast by Applications
     8.4.1. Immunoglobulin Ribavirin Antivirals Steroids Prophylactic Antibiotics Combination Treatment  
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. North America Bird Flu Treatment Market Size and Volume Forecast by End Users
     8.7.1. Institutional Health Centers Hospitals Clinics
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Bird Flu Treatment Demand Share Forecast, 2019-2026
9. Latin America Bird Flu Treatment Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Bird Flu Treatment Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Bird Flu Treatment Market Size and Volume Forecast by Applications
     9.4.1. Immunoglobulin Ribavirin Antivirals Steroids Prophylactic Antibiotics Combination Treatment  
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Latin America Bird Flu Treatment Market Size and Volume Forecast by End Users
     9.7.1. Institutional Health Centers Hospitals Clinics
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Bird Flu Treatment Demand Share Forecast, 2019-2026
10. Europe Bird Flu Treatment Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Bird Flu Treatment Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Bird Flu Treatment Market Size and Volume Forecast by Applications
     10.4.1. Immunoglobulin Ribavirin Antivirals Steroids Prophylactic Antibiotics Combination Treatment  
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Europe Bird Flu Treatment Market Size and Volume Forecast by End Users
     10.7.1. Institutional Health Centers Hospitals Clinics
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Bird Flu Treatment Demand Share Forecast, 2019-2026
11. Asia Pacific Bird Flu Treatment Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Bird Flu Treatment Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Bird Flu Treatment Market Size and Volume Forecast by Applications
     11.4.1. Immunoglobulin Ribavirin Antivirals Steroids Prophylactic Antibiotics Combination Treatment  
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Asia Pacific Bird Flu Treatment Market Size and Volume Forecast by End Users
     11.7.1. Institutional Health Centers Hospitals Clinics
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Bird Flu Treatment Demand Share Forecast, 2019-2026
12. Middle East & Africa Bird Flu Treatment Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Bird Flu Treatment Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Bird Flu Treatment Market Size and Volume Forecast by Applications
     12.4.1. Immunoglobulin Ribavirin Antivirals Steroids Prophylactic Antibiotics Combination Treatment  
  12.5. Basis Point Share (BPS) Analysis by Applications
  12.6. Y-o-Y Growth Projections by Applications
  12.7. Middle East & Africa Bird Flu Treatment Market Size and Volume Forecast by End Users
     12.7.1. Institutional Health Centers Hospitals Clinics
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Bird Flu Treatment Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Bird Flu Treatment Market: Market Share Analysis
  13.2. Bird Flu Treatment Distributors and Customers
  13.3. Bird Flu Treatment Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. AbbVie Inc. Abbott Laboratories Alltech, Inc. BioCryst Pharmaceuticals, Inc. Aurobindo Pharma Ltd. Cipla Ltd.  
Segments Covered in the Report
The global bird flu treatment market has been segmented on the basis of

Types
  • Immunoglobulin
  • Ribavirin
  • Antivirals
  • Steroids
  • Prophylactic Antibiotics
  • Combination Treatment
  • Others
End-users
  • Institutional Health Centers
  • Hospitals
  • Clinics
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • AbbVie Inc.
  • Abbott Laboratories
  • Alltech, Inc.
  • BioCryst Pharmaceuticals, Inc.
  • Aurobindo Pharma Ltd.
  • Cipla Ltd.
  • Bristol-Myers Squibb Co.
  • Chewy, Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • F. Hoffmann-La Roche AG
  • Forest Pharmaceuticals, Inc.
  • GlaxoSmithKline PLC.
  • Gilead Sciences Inc.
  • Johnson & Johnson Services, Inc.
  • Merck & Co.
  • Macleods Pharmaceuticals Ltd.
  • Novartis International AG
  • Sinovac Biotech Ltd.
  • Pfizer Inc.
  • Sanofi S.A.

Some of the major players competing in the market are AbbVie Inc.; Abbott Laboratories; Alltech, Inc.; BioCryst Pharmaceuticals, Inc.; Aurobindo Pharma Ltd.; Cipla Ltd.; Bristol-Myers Squibb Co.; Chewy, Inc.; Dr. Reddy’s Laboratories Ltd.; F. Hoffmann-La Roche AG; Forest Pharmaceuticals, Inc.; GlaxoSmithKline PLC.; Gilead Sciences Inc.; Johnson & Johnson Services, Inc.; Merck & Co.; Macleods Pharmaceuticals Ltd.; Novartis International AG; Sinovac Biotech Ltd.; Pfizer Inc.; and Sanofi S.A. These major players are implementing various marketing strategies such as capital investments, merger & acquisitions, and new product development to enhance their market position in the regional as well as global competition.

Bird Flu Treatment Market By Key Players

Buy Report